Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: Rationale for its use in combination therapy-Reference-Cited by-同舟云学术

Methotrexate inhibits the viability of human melanoma cell lines and enhances Fas/Fas-ligand expression, apoptosis and response to interferon-alpha: Rationale for its use in combination therapy

Published:2014-12 Issue: Volume:563 Page:101-107
ISSN:0003-9861
Container-title:Archives of Biochemistry and Biophysics
language:en
Short-container-title:Archives of Biochemistry and Biophysics

Author:

Nihal Minakshi,Wu Jianqiang,Wood Gary S.

Funder

Department of Veterans Affairs (GSW) and NCI

Publisher

Elsevier BV

Subject

Molecular Biology,Biochemistry,Biophysics

Reference40 articles.

1. Which drug, and when, for patients with BRAF-mutant melanoma?

2. Treatment of BRAF-Mutant Melanoma: The Role of Vemurafenib and Other Therapies

3. Pattern of chromosomal replication in synchronized lymphocytes

4. Doxorubicin in combination with fluorouracil and cyclophosphamide (i.v. FAC regimen, day 1, 21) versus methotrexate in combination with fluorouracil and cyclophosphamide (i.v. CMF regimen, day 1, 21) as adjuvant chemotherapy for operable breast cancer: a study by the GEICAM group

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Approaches to autoimmune diseases using epigenetic therapy;Epigenetics in Human Disease;2024

2. Cellular senescence signaling in cancer: A novel therapeutic target to combat human malignancies;Biochemical Pharmacology;2022-05

3. Antifolate-based anticancer drugs;New Strategies Targeting Cancer Metabolism;2022

4. Benefit/risk Ratio of Low-dose Methotrexate in Cutaneous Lesions of Mycosis Fungoides and Sézary Syndrome;Acta Dermato Venereologica;2021

5. DNA methylation signatures of autoimmune diseases in human B lymphocytes;Clinical Immunology;2021-01